Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.63 |
| ▸ | MPO | P05164 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 2/20 | 0.46 |
| ▸ | TEK | Q02763 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14106165 | 0.96 | PTPN1 (0.63) | PTPN1MPOFFAR1LMNALCK | |
| SCHEMBL14105816 | 0.89 | PTPN1 (0.68) | PTPN1MPOFFAR1LMNALCK | |
| SCHEMBL14149922 | 0.83 | PLG (0.59) | MPOLMNARXFP1PPARGPPARD | |
| SCHEMBL3914823 | 0.82 | NPC1 (0.59) | PPARGPPARDPPARANR1H4PTGS1 | |
| SCHEMBL14106173 | 0.81 | HTT (0.63) | PTPN1LMNARXFP1PTGS1ALDH1A1 | |
| SCHEMBL9885470 | 0.80 | PTPN1 (0.59) | PTPN1MPOFFAR1LCKTEK | |
| SCHEMBL14106193 | 0.79 | PTPN1 (0.60) | PTPN1FFAR1LMNALCKTEK | |
| SCHEMBL14149920 | 0.79 | PLG (0.59) | MPOLMNARXFP1PPARGPPARD | |
| SCHEMBL23880571 | 0.78 | PTPN1 (1.00) | PTPN1FFAR1 | |
| SCHEMBL30042099 | 0.78 | PTPN1 (1.00) | PTPN1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7402696-B2 | Benzene compounds | AJINOMOTO CO., INC. (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20070105899-A1 | Benzene compounds | AJINOMOTO CO., INC. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105899-A1 | Benzene compounds | ACACB, ACACA, FABP4 | PTPN1 3143/4885MPO 316/4885FFAR1 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.